logo
AAT Bioquest

(-)-Blebbistatin *CAS#: 856925-71-8*

Product Image
Product Image
Gallery Image 1
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Physical properties
Molecular weight292.33
SolventDMSO
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
UNSPSC12352200

OverviewpdfSDSpdfProtocol


CAS
856925-71-8
Molecular weight
292.33
(-)-Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of 2 µM. It does not inhibit myosin light chain kinase, inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly.

Calculators


Common stock solution preparation

Table 1. Volume of DMSO needed to reconstitute specific mass of (-)-Blebbistatin *CAS#: 856925-71-8* to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.

0.1 mg0.5 mg1 mg5 mg10 mg
1 mM342.079 µL1.71 mL3.421 mL17.104 mL34.208 mL
5 mM68.416 µL342.079 µL684.158 µL3.421 mL6.842 mL
10 mM34.208 µL171.04 µL342.079 µL1.71 mL3.421 mL

Molarity calculator

Enter any two values (mass, volume, concentration) to calculate the third.

Mass (Calculate)Molecular weightVolume (Calculate)Concentration (Calculate)Moles
/=x=

Images


References


View all 41 references: Citation Explorer
The mechanical uncoupler blebbistatin is associated with significant electrophysiological effects in the isolated rabbit heart
Authors: Brack KE, Narang R, Winter J, Ng GA.
Journal: Exp Physiol (2013): 1009
Homology model of nonmuscle myosin heavy chain IIA and binding mode analysis with its inhibitor blebbistatin
Authors: Lv Y, Lu S, Lu T, Kou J, Yu B.
Journal: J Mol Model (2013): 1801
Enrichment of cell populations in metaphase, anaphase, and telophase by synchronization using nocodazole and blebbistatin: a novel method suitable for examining dynamic changes in proteins during mitotic progression
Authors: Matsui Y, Nakayama Y, Okamoto M, Fukumoto Y, Yamaguchi N.
Journal: Eur J Cell Biol (2012): 413
Modifications of mechanoelectric feedback induced by 2,3-butanedione monoxime and Blebbistatin in Langendorff-perfused rabbit hearts
Authors: Brines L, Such-Miquel L, Gallego D, Trapero I, Del Canto I, Zarzoso M, Soler C, Pelechano F, Canoves J, Alberola A, Such L, Chorro FJ.
Journal: Acta Physiol (Oxf) (2012): 29
Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light
Authors: Mikulich A, Kavaliauskiene S, Juzenas P.
Journal: Biochim Biophys Acta (2012): 870
The role of dynamic instability and wavelength in arrhythmia maintenance as revealed by panoramic imaging with blebbistatin vs. 2,3-butanedione monoxime
Authors: Lou Q, Li W, Efimov IR.
Journal: Am J Physiol Heart Circ Physiol (2012): H262
Properties of blebbistatin for cardiac optical mapping and other imaging applications
Authors: Swift LM, Asfour H, Posnack NG, Arutunyan A, Kay MW, Sarvazyan N.
Journal: Pflugers Arch (2012): 503
Inhibition of suicidal erythrocyte death by blebbistatin
Authors: Lang E, Qadri SM, Zelenak C, Gu S, Rotte A, Draeger A, Lang F.
Journal: Am J Physiol Cell Physiol (2011): C490
Perivascular delivery of blebbistatin reduces neointimal hyperplasia after carotid injury in the mouse
Authors: Huang J, Zhang J, Pathak A, Li J, Stouffer GA.
Journal: J Pharmacol Exp Ther (2011): 116
In vitro and in vivo relaxation of urinary bladder smooth muscle by the selective myosin II inhibitor, blebbistatin
Authors: Zhang X, Kuppam DS, Melman A, DiSanto ME.
Journal: BJU Int (2011): 310